Physician profile
Evan Boyd
NPI 1134623598
$41,202.49
in general payments reported to CMS, 2019-2025
13 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $26K · 2024: $14K · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Education: $5,833 · Travel and Lodging: $5,393 · Food and Beverage: $2,643 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,833.33 |
| Education | $5,833.33 |
| Travel and Lodging | $5,392.55 |
| Food and Beverage | $2,643.28 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,609.15 | 2023-2024 | |
| Smith+Nephew, INC. | $13,018.66 | 2023-2024 | Q-Fix, Spatial Frame, Na |
| Stryker Corporation | $2,454.29 | 2023-2025 | Iconix, Alphavent, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $1,630.50 | 2024 | |
| Encore Medical, LP | $1,500.00 | 2024 | Djo Surgical |
| Prodigy Surgical Distribution, INC. | $199.93 | 2025 | |
| Miach Orthopaedics, INC. | $179.83 | 2024 | |
| Zimmer Biomet Holdings, INC. | $140.32 | 2025 | Osseofit |
| Ferring Pharmaceuticals INC. | $131.65 | 2025 | Euflexxa |
| Vericel Corporation | $121.95 | 2023 | Maci |
| Davol INC. | $112.29 | 2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $73.71 | 2024 | Dynacord |
| Kairos Surgical INC | $30.21 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.